Long term pharmacy funding agreement reached in England


Responsive image

On Monday of this week PSNC, the Department of Health and Social Care (DHSC) and NHS England and Improvement (NHSE&I) announced that they had reached agreement on a five-year deal for community pharmacy in England.

The funding of the community pharmacy contract has been fixed at £2.592 billion for the next 5 years. It is disappointing that there is no increase in the funding of the pharmacy contract over this period as in real terms when inflation is taken into account it is a reduction in funding over the period of the agreement. However it appears that the intention of the government was initially to reduce the global sum so this can be viewed as an investment to recognise the contribution that community pharmacy can make towards the delivery of the NHS long term plan.

The agreement also signposts the development and implementation of a number of new services within the funding of the contract starting with a new Community Pharmacy Consultation Service which will be introduced later in this NHS year and will replace the NUMSAS and DMIRS services. Medicines Use Reviews will be phased out over the remainder of this year and during 2020/2021 and the remuneration associated with this service and the establishment payment which will end in March 2020, will be invested into new clinical services. The quality points scheme is being replaced with a new Pharmacy Quality Scheme which will commence in October 2019.

Further detail about the agreement can be found by following the link psnc.org.uk/5yearCPCFpsnc.org.uk/5yearCPCF We will keep you informed through our website as more information about the new service developments is released.